Daily Derm Times: August 20, 2025

Author(s):

Maddi Hebebrand, MC, Associate Editor

Key Takeaways

The TAMES-02 trial evaluates TolaSure for Epidermolysis Bullosa Simplex, highlighting advancements in treatment options for this condition.
Evolus aims to expand its dermal filler portfolio with Evolysse Sculpt, a hyaluronic acid gel targeting mid-face volume loss, pending FDA approval.
Gene expression profiling is revolutionizing melanoma management, enhancing patient care and dermatology innovation.
Patient trust in AI and telehealth integration depends on oversight and endorsement from trusted clinicians.
World Skin Health Day focuses on enhancing skin health awareness, access, and equity in underserved communities globally.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Journal Digest: August 20, 2025

This review of the latest dermatologic studies includes a case study of coexisting alopecia and BP treatment, hypochlorous acid for epidermolysis bullosa wounds, DMG-Na and caffeine for hair loss, and more.

Karen McGuire, PhD, on Advancing TAMES-02 Trial for EB Simplex

Karen McGuire, PhD, discusses TAMES-02, a clinical trial evaluating TolaSure for Epidermolysis Bullosa Simplex.

Evolus Submits Evolysse Sculpt for FDA Approval, Expanding HA Dermal Filler Portfolio

Evolus advances facial aesthetics with Evolysse Sculpt, a new hyaluronic acid gel targeting mid-face volume loss, pending FDA approval.

Unpacking the Role of Gene Expression Profiling in Melanoma

At DERM 2025, David Cotter, MD, PhD, shared how GEP testing revolutionizes skin cancer management and enhances patient care at the forefront of dermatology innovation.

Patient Trust Hinges on Clinician Oversight in AI and Telehealth

Oversight and endorsement from trusted clinicians were consistent patient requirements for integrating both AI and telemedicine.

Henry W. Lim, MD, on World Skin Health Day's Global Push for Prioritizing Dermatology

World Skin Health Day unites global dermatology leaders to enhance skin health awareness, access, and equity in underserved communities worldwide.

Highlighting Individualized Strategies in Vitiligo Care Across Diverse Cases

At a Dermatology Times Case-Based Roundtable event, Pearl Grimes, MD, led discussions on diverse vitiligo cases spanning adult, pediatric, and rapidly progressive disease, emphasizing individualized treatment strategies.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!